97888-80-7 Usage
Uses
Used in Pharmaceutical and Agrochemical Industries:
4-Benzyloxy-3,5-dimethylbenzoic acid is utilized as a building block in organic synthesis for the preparation of various pharmaceuticals and agrochemicals. Its unique structure allows for the development of new compounds with potential therapeutic and pesticidal properties.
Used in Organic Synthesis:
4-Benzyloxy-3,5-dimethylbenzoic acid is used as a key intermediate in the synthesis of complex organic molecules. Its versatile chemical properties enable the formation of a wide range of derivatives, expanding the scope of chemical research and development.
Used in Material Science:
4-Benzyloxy-3,5-dimethylbenzoic acid is employed in the development of new materials, such as liquid crystals and polymers. Its structural characteristics contribute to the unique properties of these materials, making them suitable for various applications in electronics, optics, and other industries.
Used in Biological Research:
4-Benzyloxy-3,5-dimethylbenzoic acid has been studied for its potential biological activities, including anti-inflammatory and anticancer properties. Its ability to modulate various biological pathways makes it a promising candidate for further research and development in the field of medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 97888-80-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,7,8,8 and 8 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 97888-80:
(7*9)+(6*7)+(5*8)+(4*8)+(3*8)+(2*8)+(1*0)=217
217 % 10 = 7
So 97888-80-7 is a valid CAS Registry Number.
InChI:InChI=1/C16H16O3/c1-11-8-14(16(17)18)9-12(2)15(11)19-10-13-6-4-3-5-7-13/h3-9H,10H2,1-2H3,(H,17,18)/p-1
97888-80-7Relevant academic research and scientific papers
Nitrogen-containing fused ring compounds and use thereof
-
Page/Page column 82, (2010/11/25)
A URAT1 activity inhibitor containing a nitrogen-containing fused ring compound represented by the following formula [1]: wherein each symbol is as defined in the description. The present invention is useful for the prophylaxis or treatment of pathology showing involvement of uric acid, such as hyperuricemia, gouty tophus, acute gouty arthritis, chronic gouty arthritis, gouty kidney, urolithiasis, renal function disorder, coronary artery disease, ischemic heart disease and the like.
Inhibitors of caspases
-
, (2008/06/13)
The present invention relates to novel classes of compounds which are caspase inhibitors, in particular interleukin-1β converting enzyme (“ICE”) inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting caspase activity and consequently, may be advantageously used as agents against interleukin-1-(“IL-1”), apoptosis-, interferon-γ inducing factor-(IGIF), or interferon-γ-(“IFN-γ”) mediated diseases, including inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, and degenerative diseases. This invention also relates to methods for inhibiting caspase activity and decreasing IGIF production and IFN-γ production and methods for treating interleukin-1, apoptosis-, and interferon-γ-mediated diseases using the compounds and compositions of this invention. This invention also relates to methods of preparing the compounds of this invention.
